limited published evidence regarding combined formulations
doi: 10.3389/fphar.2021.632295 Received 07 December 2020 Accepted 13 April 2021 Published 10 June 2021 Volume 12 - 2021 Edited by Chiara Bianca Maria Platania, University of Catania, Italy Reviewed by Doreen Schmidl, Medical University of Vienna, Austria Francesca Lazzara, University of Catania, Italy Updates Copyright 2021 Zlatar, Kokot, Vuletic, Masnec, Kralj, Perisa, Barisic, Radic, Milanovic, Drmic, Seiwerth and Sikiric
Sources and further reading FDA evaluation of BPC-157-related bulk drug substances, 11 May 2026 FDA Pharmacy Compounding Advisory Committee briefing, July 2026 FDA: bulk drug substances that may present significant safety risks TGA and Australian Chief Medical Officer: unapproved peptide products, 19 June 2026 World Anti-Doping Agency: 2026 Prohibited List Early BPC research indexed by PubMed Review of BPC-157 and musculoskeletal soft-tissue healing Recent review calling for well-designed human trials Researcher, clinician or journalist
Avoid covering the original product name, lot, or expiration date
Some people take supplements to top up low B vitamin levels
